Levaquin, Cipro, Avelox Nerve Damage Lawsuit

nerve-damageLevaquin, Cipro, and Avelox are antibiotics that have been linked to permanent nerve damage in patients. Levaquin, Cipro and Avelox are part of a class of antibiotics known as fluoroquinolones. Fluoroquinolones have been linked to the onset of irreversible nerve damage called “peripheral neuropathy,” according to the FDA and several medical journals.

We Can Tell You If You Have a Claim and Help You Pursue Compensation, with No Cost to You

Borri Law Offices is accepting Levaquin, Cipro, and Avelox nerve damage cases. If you took Levaquin, Cipro, or Avelox and suffered peripheral neuropathy you may be entitled to substantial compensation.

We offer a free consultation. Call us or submit the contact form on the bottom of the page to speak to an experienced nerve damage lawyer about your case.

What are Levaquin, Cipro, and Avelox?

Levaquin, Cipro, and Avelox are broad-spectrum antibiotics that are commonly used to treat a variety of illnesses caused by bacterial infections, such as respiratory and urinary tract infections, skin, bone and joint infections, and sinusitis. Many patients are treated with Levaquin, Cipro, Avelox, and other fluoroquinolone antibiotics. More than 23 million patients received a prescription for a fluoroquinolone in 2011.

Fluoroquinolones Linked to Irreversible Nerve Damage

As early as 1992, there were reports of nerve damage associated with fluoroquinolone use. In 1996, a study in the Journal of Antimicrobial Chemotherapy found 37 cases of peripheral nerve damage related to fluoroquinolones. A 2001 study in the Annals of Pharmacotherapy documented 45 adverse events associated with fluoroquinolones and long-term peripheral neuropathy.

After numerous adverse events were reported to the FDA in 2002 and 2003, the labels on fluoroquinolone drugs, such as Levaquin, Cipro, and Avelox were changed to note that peripheral neuropathy was a possible adverse effect of fluoroquinolone use but listed it as “rare.”

In August 2013, an FDA review determined that existing warnings for fluoroquinolones were inadequate. The FDA’s newest alert requires that all drug labels and medication guides for fluoroquinolones be updated to better emphasize the risk for serious, rapid-onset, and potentially irreversible peripheral neuropathy. The new FDA-mandated warning also advises patients who experience symptoms of nerve damage to discontinue use of Levaquin, Cipro, and Avelox immediately.

What is Peripheral Neuropathy?

Peripheral neuropathy refers to the conditions that result when nerves that carry messages to and from the brain and spinal cord from and to the rest of the body are damaged or diseased. Damage to these nerves interrupts communication between the brain and other parts of the body and can impair muscle movement, prevent normal sensation in the arms and legs, and cause pain and abnormal sensations.

Symptoms of peripheral neuropathy include:

  • Pain
  • Burning sensation
  • Tingling
  • Numbness
  • Weakness
  • Nerve spasms
  • Changes in sensation to light touch, pain, and temperature
  • Changes in sensation to the body position

Peripheral neuropathy symptoms typically begin rapidly, within a few days of starting the fluoroquinolones. Nerve damage symptoms may last for months or even be permanent, despite stopping the drug.

The risk for peripheral neuropathy appears to affect only those who take fluoroquinolones by mouth or by injection. Fluoroquinolones used in the eyes or ears are not linked to the risk.

What are Levaquin, Cipro and Avelox Lawsuits Claiming?

Patients who took Levaquin, Cipro or Avelox and suffered nerve damages have filed lawsuits claiming that the manufacturers of these drugs, including Johnson & Johnson and Bayer, ignored information about the link between fluoroquinolones and peripheral neuropathy for years and failed to adequately warn patients and doctors about the risk of permanent and long-lasting nerve damage.

It is also claimed that warning labels for Levaquin, Cipro and Avelox misled patients and their doctors by inaccurately advising patients and physicians that peripheral neuropathy nerve damage in patients was “rare” and in any case could be reversed by discontinuing use of the drug upon the onset of symptoms. However, the onset of irreversible peripheral neuropathy is often rapid and discontinuation of the drugs will not ensure that the nerve damage is cured.

Levaquin, Cipro or Avelox Recall

There has been no Levaquin, Cipro or Avelox recall. Johnson & Johnson continues to manufacture and sell Levaquin, and Bayer continues to sell Cipro and Avelox.

Is There a Levaquin, Cipro or Avelox Class Action Lawsuit?

There are no Levaquin, Cipro or Avelox nerve damage class action lawsuits. At Borri Law Offices, we file an individual case for each of our clients. We spend the time to understand your individual situation.

Do I Have a Levaquin, Cipro or Avelox Nerve Damage Lawsuit?

Borri Law Offices is accepting Levaquin, Cipro or Avelox nerve damage cases. If you or someone you love took Levaquin, Cipro or Avelox and experienced peripheral neuropathy, you should contact us today. For a free consultation about your case, call us toll-free at 888-767-6565, or fill out the contact form at the bottom of the page and one of our lawyers will contact you.


August 17, 2015 – All federal lawsuits claiming that Levaquin, Avelox and Cipro cause the development of irreversible peripheral neuropathy (nerve damage) and that the manufacturers of these antibiotics failed to adequately warn doctors and patient of that risk, are transferred to Minnesota Federal District Court and assigned to Judge John Tunheim for coordinated pretrial proceedings.

Free Case Evaluation